A gene therapy company dedicated to revolutionizing the treatment of bladder cancer through innovative science and commitment to patient care.
Joined February 2020
- Tweets28
- Following37
- Followers89
- Likes3
.@medicine_maker featured interviews with cell and gene therapy innovators, including FerGene CEO David Meek. In the article, industry leaders speak about what excites them most about cell and gene therapy. bit.ly/MedMaker #bladdercancer #genetherapy
Hear from @VikramNarayan who
presented new data at #SUO today on
nadofaragene firadenovec bit.ly/NFSUO20, bit.ly/Abstract1313, bit.ly/Poster23, bit.ly/Poster38 @UroOnc
Hear from Dr. Gennady Bratslavsky, President of the SUO-CTC, about a recent @TheLancetOncol publication for the treatment of #bladdercancer & the role #SUOCTC had in developing the investigational treatment. bit.ly/LancetPressRelease
New analyses from a study evaluating nadofaragene firadenovec were presented today at SUO. Dr. Robert Svatek explains why these data are exciting for the #urologycommunity. bit.ly/NFSUO20, bit.ly/Abstract1313, bit.ly/Poster23, bit.ly/Poster38 @UroOnc
Today FerGene announced new data
results to be presented at #SUO from the
Phase 3 clinical trial for nadofaragene
firadenovec. bit.ly/NFSUO20, bit.ly/Abstract1313, bit.ly/Poster23, bit.ly/Poster38 @UroOnc
We're grateful to the investigators, patients, Dr. Nigel Parker & Prof Seppo Yia-Herftala of #FKDTherapies & #SUOCTC for the important findings highlighted in @TheLancetOncol publication of Phase 3 data. bit.ly/LancetPhase3, bit.ly/CommentaryLancetNadof… @UroOnc @BladderCancerUS
.@TheLancetOncol published a study
evaluating our investigational treatment.
Dr. Gennady Bratslavsky, President of the
#SUOCTC, explains why this data is
exciting for the #urology community at the
link: bit.ly/LancetPressRelease @UroOnc @BladderCancerUS
We’re excited to share @TheLancetOncol
has published data from the Phase 3
clinical trial of nadofaragene firadenovec.
Learn more: bit.ly/LancetPhase3 , bit.ly/CommentaryLancetNadof… @BladderCancerUS @UroOnc #SUOCTC
FerGene’s CEO, David Meek, will be a keynote speaker at Reuters Events’ new Cell & Gene Therapy Conference, taking place on Nov 2. It's free to join. Sign up here bit.ly/3amHNqb and we hope to see you all there, virtually! #genetherapy #biotech
FerGene is proud to sponsor the Bladder Cancer Advocacy Network (BCAN) virtual Think Tank event, a premier gathering of the top minds in science and research. Together we will achieve more in the fight against bladder cancer. #BCAN bit.ly/3fz3tAr
Today, our CEO David Meek signed @MassBio’s CEO Pledge for a More Equitable and Inclusive Life Sciences Industry. We know there is more work to do to build a diverse and equitable future in the life sciences industry and we are fully committed to doing our part. #diversity
Excited to announce three top #biotech leaders have been added to our executive team who share our passion for revolutionizing the treatment of #bladdercancer. Learn more about our team: bwnews.pr/3hBfA2a
We salute patient advocates like Tom who are doing their part to increase awareness of #bladdercancer and support patients and families, especially during #BladderCancerAwarenessMonth. We’re proud to partner with @BladderCancerUS and the bladder cancer community.
At FerGene, we’re dedicated to advocating for the ~700,000 people living with bladder cancer in the U.S. Our goal is to provide greater hope for this community and bring them innovative solutions for managing their care. #BladderCancerAwarenessMonth
Ben is a medical science liaison at FerGene who works with healthcare providers to find solutions for bladder cancer. Ben and his family joined so many others last week in the @BladderCancerUS virtual walk to end #bladdercancer. Thank you, Ben!
Earlier this week, our FerGene team participated in the BCAN Virtual Walk to End Bladder Cancer. Thanks to @BladderCancerUS for organizing – we were humbled to join everyone from home to show support for the #bladdercancer community during #BladderCancerAwarenessMonth
It's VIRTUAL Walk Season. Join @BladderCancerUS on May 2, 2020 for the Virtual Walk to End Bladder Cancer. It's fun, it's easy and it's worthwhile to help end the #7 most common cancer in the U.S.
Why not take your normal walk around the neighborhood on May 2, but help save lives? @BladderCancerUS Virtual Walk to End Bladder Cancer will bring together hundreds of people to have fun, connect safely, & help end one of the most common cancers. Join us: bit.ly/2R2peiM
Join @BladderCancerUS on May 2 for exercise, connecting with friends and family safely, and most importantly, helping to end one of the most common yet least known cancers in the United States: #bladdercancer.
Join us: bit.ly/2R2peiM
